-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283

Benzinga·03/12/2026 12:56:03
Listen to the news
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $271 to $283.